Trial · NCT04042857
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 13 of 13
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Mycological Cure at 48 Weeks | Baseline to 48 Weeks | Mycological cure rate at week 48 as defined by negative potassium hydroxide examination and negative culture of the target hallux nail |
| Primary | Clinical Efficacy at 48 Weeks | Baseline to 48 Weeks | Clinical efficacy rate at week 48 as defined by less than 10% clinical involvement of the target hallux nail |
| Secondary | Complete Cure at Week 48 | Baseline to 48 Weeks | Complete cure rate at week 48 defined as 0% clinical involvement, negative potassium hydroxide examination and negative culture of the target hallux nail |
| Secondary | Complete Cure at Week 52 | Baseline to 52 Weeks | Complete cure rate at week 52 defined as 0% clinical involvement, negative mycology, and negative potassium hydroxide examination of the target hallux nail at week 52 |
| Secondary | Almost Complete Cure at Week 48 | Baseline to 48 Weeks | Almost complete cure rate at week 48 defined as less than 10% clinical involvement, negative potassium hydroxide examination, and negative culture of the target hallux nail at week 48 |
| Secondary | Almost Complete Cure at Week 52 | Baseline to Week 52 | Almost complete cure rate at week 52 defined as less than 10% clinical involvement, negative potassium hydroxide examination, and negative culture of the target hallux nail at Week 52 |
| Secondary | Time to Complete Cure | Baseline to 52 Weeks | Measured across all observation points |
| Secondary | Time to Almost Complete Cure | Baseline to 52 Weeks | Measured across all observation points |
| Secondary | Percent Change in Area of Nail Involvement | Baseline to 52 Weeks | Calculated as a ratio of clear to involved measured across all observation points |
| Secondary | Growth of Clear Nail | Baseline to 52 Weeks | Change in area of clear nail growth measured across all observation points |
| Secondary | Mycological Cure Rate | Baseline to 52 Weeks | Changes in mycological cure rates (Changes in the proportion of subjects who achieved mycological cure, defined as negative culture and potassium hydroxide examination) measured across all observation points |
| Secondary | Dermatopyhyte Identification and Characterization | Baseline to 52 Weeks | Changes in the types of dermatophytes dermatophytes across all observation points |
| Secondary | Overall Fungal Species | Baseline to 52 Weeks | Change types of overall fungal species across all observation points |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04042857/registered